Innovent released the results of two clinical studies of IBI311 (an anti-IGF-1R monoclonal antibody) in oral presentations at the Asia-Pacific Academy of Ophthalmology Congress and International Congress of Endocrinology 2024 ...Middle East

ROCKVILLIE, Md. and SUZHOU, China, March 6, 2024 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high quality medicines for the treatment of cancer, metabolic, autoimmune,...

Hence then, the article about innovent released the results of two clinical studies of ibi311 an anti igf 1r monoclonal antibody in oral presentations at the asia pacific academy of ophthalmology congress and international congress of endocrinology 2024 was published today ( Thursday 07/03/2024 - 06:45 AM ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Innovent released the results of two clinical studies of IBI311 (an anti-IGF-1R monoclonal antibody) in oral presentations at the Asia-Pacific Academy of Ophthalmology Congress and International Congress of Endocrinology 2024 )

Also on site :

• Costco’s $25 Glassware Set Is Giving Anthropologie Vibes for Less
• Pentagon wants killer AI without safeguards – Reuters
• '90s Grunge Rock Band's Hits Revived in Special Tribute Performance